Selected Publications
Lee SH, Geng H, Arnold J, Caruana R, Fan Y, Rosen MA, Apte AP, Deasy JO, Bradley JD, Xiao Y.: Interpretable Machine Learning for Choosing Radiation Dose-volume Constraints on Cardio-pulmonary Substructures Associated with Overall Survival in NRG Oncology RTOG 0617
Int J Radiat Oncol Biol Phys. 23 : 591-596,2023.
Narasimhamurthy M, Savant D, Shreve L, Rosen MA, Lee MK, Cooper K, Furth EE, Zhang PJ, Yang Z.: Myofibroblastoma in the Liver: A Case Report and Review of Literature
Int J Surg Pathol. : 2023.
Boss MA, Snyder BS, Kim E, Flamini D, Englander S, Sundaram KM, Gumpeni N, Palmer SL, Choi H, Froemming AT, Persigehl T, Davenport MS, Malyarenko D, Chenevert TL, Rosen MA.: Repeatability and Reproducibility Assessment of the Apparent Diffusion Coefficient in the Prostate: A Trial of the ECOG-ACRIN Research Group (ACRIN 6701)
J Magn Reson Imaging 56 (3): 2022.
Romanello Joaquim M, Furth EE, Fan Y, Song HK, Pickup S, Cao J, Choi H, Gupta M, Cao Q, Shinohara R, McMenamin D, Clendenin C, Karasic TB, Duda J, Gee JC, O'Dwyer PJ, Rosen MA, Zhou R.: DWI Metrics Differentiating Benign Intraductal Papillary Mucinous Neoplasms from Invasive Pancreatic Cancer: A Study in GEM Models
Cancers (Basel) 14 (16): 2022.
Mettikanont P, Kalluri A, Bittermann T, Phillips N, Loza BL, Rosen M, Siegelman E, Furth E, Abt P, Olthoff K, Shaked A, Hoteit M, Reddy KR.: The Course of LIRADS 3 and 4 Hepatic Abnormalities as Correlated With Explant Pathology: A Single Center Experience
J Clin Exp Hepatol 4 : 1048-1056,2022.
Wattenberg MM, Asch D, Yu S, O'Dwyer PJ, Domchek SM, Nathanson KL, Rosen MA, Beatty GL, Siegelman ES, Reiss KA: Platinum response characteristics of patients
with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2
mutation. Br J Cancer : 2020.
Newitt DC, Zhang Z, Gibbs JE, Partridge SC, Chenevert TL, Rosen MA, Bolan PJ, Marques HS, Aliu S, Li W, Cimino L, Joe BN, Umphrey H, Ojeda-Fournier H, Dogan B, Oh K, Abe H, Drukteinis J, Esserman LJ, Hylton NM; ACRIN Trial Team and I-SPY 2 TRIAL Investigators: Test-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial J Magn Reson Imaging. 6 (49): 1617-1628,2019.
Partridge SC, Newitt DC, Chenevert TL, Rosen MA, Hylton NM; ACRIN 6698 Trial, Team and I-SPY 2: Diffusion-weighted MRI in Multicenter
Trials of Breast Cance Radiology 2 (291): 546,2019.
Partridge SC, Zhang Z, Newitt DC, Gibbs JE, Chenevert TL, Rosen MA, Bolan PJ, Marques HS, Romanoff J, Cimino L, Joe BN, Umphrey HR, Ojeda-Fournier H, Dogan B, Oh K, Abe H, Drukteinis JS, Esserman LJ, Hylton NM; ACRIN 6698 Trial Team and I-SPY 2 Trial Investigators: Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial. Radiology 3 (289): 2018.
Scheel JR, Kim E, Partridge SC, Lehman CD, Rosen MA, Bernreuter WK, Pisano ED, Marques HS, Morris EA, Weatherall PT, Polin SM, Newstead GM, Esserman LJ, Schnall MD, Hylton NM: MRI,
Clinical Examination, and Mammography for Preoperative Assessment of Residual
Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for
Breast Cancer: ACRIN 6657 Trial AJR Am J Roentgenol 210 (6): 1376-1385,2018.
Academic Contact Information
Department of Radiology
Hospital of the University of Pennsylvania
1 Silverstein
3400 Spruce Street
Philadelphia,
PA
19104-4283
Phone: 215-662-3107